Induced pluripotent stem cells derived from human amnion in chemically defined conditions

Area of Science:

• Stem Cell Biology
• Regenerative Medicine
• Genomics

Background:

• Fetal stem cells possess multipotency with some pluripotent features.
• Clinical applications are limited by their current differentiation potential.
• Enhancing pluripotency could expand cell-based therapies for pediatrics and disease modeling.

Purpose of the Study:

• To reprogram human amnion mesenchymal stem cells to a pluripotent state (AM-iPSC) using episomal methods.
• To characterize the pluripotency and differentiation capacity of the generated AM-iPSC lines.
• To identify genetic factors influencing pluripotency variability in stem cell lines.

Main Methods:

• Episomal reprogramming of human amnion mesenchymal stem cells in chemically defined media.
• Characterization of AM-iPSC lines for embryonic stem cell markers and teratoma formation.
• Computational analysis of microarray and RNA sequencing data to assess pluripotency levels.
• Differential gene expression analysis to identify regulatory factors of pluripotency variability.

Main Results:

• Successfully generated AM-iPSC lines expressing embryonic stem cell markers.
• AM-iPSC lines formed teratomas with derivatives from all three germ layers and maintained a normal karyotype.
• Computational analysis confirmed pluripotency across all tested lines, albeit with quantifiable variability.
• Identified gene groups, including metallothioneins, potentially regulating pluripotency variability.

Conclusions:

• Chemically defined reprogramming yields pluripotent stem cells from human amnion.
• Pluripotency exhibits inherent variability, influenced by specific gene expression patterns.
• Understanding this variability is crucial for predicting and optimizing cell-based therapeutic applications.